| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/11/2007 | US20070010446 As antiinflammatory agent alone or in combinaton; side effect reduction of glucocorticoid treatment; acute or chronic inflammation such as autoimmune disease, allergies, asthma, chronic obstructive pulmonary disease, psoriasis, dermatitis, Inflammatory Bowel disease |
| 01/11/2007 | US20070010444 Novel mediator of neurotransmitter and psychostimulant responses |
| 01/11/2007 | US20070010442 Inhibitor of vascular endothelial cell growth factor |
| 01/11/2007 | US20070010441 A purified binding protein bound to an imaging agent, a drug, or an antigen, and which specifically binds to the GIT receptor HPT1, hPEPT1, D2H, or hSI; time-release agents; improved bioavailability; receptor binding assay; drug screening |
| 01/11/2007 | US20070010439 Production of human parathyroid hormone from microorganisms |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070010433 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 01/11/2007 | US20070010432 Heat shock protein 90 activator |
| 01/11/2007 | US20070010430 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070010017 Lentiviral packaging constructs |
| 01/11/2007 | US20070010015 Complete empty viral particles of infectious bursal disease virus (ibdv), production method thereof and applications of same |
| 01/11/2007 | US20070009995 Prevention of incorporation of non-standard amino acids into protein |
| 01/11/2007 | US20070009994 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen |
| 01/11/2007 | US20070009993 metRS2 |
| 01/11/2007 | US20070009992 Purified mutant DNA comprising a TLR4 human genomic segment; identifying polymorphisms; expression cassettes; nucleic acid molecule of operably linked to a promoter, so that host cell expresses variant TLR4; diagnosing susceptibility to asthma, respiratory system disorders, arthritis, cystic fibrosis |
| 01/11/2007 | US20070009991 Gene expression in transgenic avians |
| 01/11/2007 | US20070009987 recombinant fusion protein comprising binding domain antibody that binds to cell-surface antigen, functional group domain for eliciting desired effect on target molecule, extension peptide between binding domain and functional group domain containing uncoupled cysteine residue capable of forming s-s bond |
| 01/11/2007 | US20070009986 Compositions for modulating immune cell activity and methods for detection thereof |
| 01/11/2007 | US20070009972 Epidermal growth factor receptor polypeptides and antibodies |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009964 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells |
| 01/11/2007 | US20070009963 Apolipoprotein biopolymer marker indicative of normal human |
| 01/11/2007 | US20070009962 Nucleic acid binding polypeptide library |
| 01/11/2007 | US20070009956 Arginine hydrochloride enhances chaperone-like activity of alpha crystallin |
| 01/11/2007 | US20070009955 Secreted polypeptide species associated with cardiovascular disorders |
| 01/11/2007 | US20070009952 detecting susceptibility for basement membrane disease such as congenital nephrotic syndromes of the Finnish type (NPHS1); proteinuria; detecting the presence or absence of a mutation in the coding region of the gene for NPHS1 |
| 01/11/2007 | US20070009951 Gene expression vaccine |
| 01/11/2007 | US20070009949 Paramyxovirus-derived RNP |
| 01/11/2007 | US20070009948 Nucleic acid binding polypeptide library |
| 01/11/2007 | US20070009947 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 01/11/2007 | US20070009945 Endothelins; renin; kits |
| 01/11/2007 | US20070009941 Complementary DNAs |
| 01/11/2007 | US20070009936 mTOR kinase-associated proteins |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009921 Fragments of virus protein 2 or 3 of polyoma virus as vehicles for active substances |
| 01/11/2007 | US20070009918 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| 01/11/2007 | US20070009917 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 01/11/2007 | US20070009916 Guanosine triphosphate-binding protein coupled receptors |
| 01/11/2007 | US20070009908 Human stanniocalcin-alpha |
| 01/11/2007 | US20070009906 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 01/11/2007 | US20070009905 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 01/11/2007 | US20070009904 Reagents for diagnosis of bacterial infection, components of effective antibacterial vaccines, and/or as targets for antibacterial drugs, including anti-S. pneumoniae drugs |
| 01/11/2007 | US20070009903 Reagents for diagnosis of bacterial infection, components of antibacterial vaccines, and/or as targets for antibacterial drugs |
| 01/11/2007 | US20070009902 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection |
| 01/11/2007 | US20070009901 molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; |
| 01/11/2007 | US20070009896 Method for detecting mutation and method of inducing the same |
| 01/11/2007 | US20070009888 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 01/11/2007 | US20070009886 Carbohydrate-associated proteins |
| 01/11/2007 | US20070009571 Novel haptotactic peptides |
| 01/11/2007 | US20070009569 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance |
| 01/11/2007 | US20070009556 Live genetically attenuated malaria vaccine |
| 01/11/2007 | US20070009554 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 01/11/2007 | US20070009553 Bacterial strains of genus exiguobacterium, culture method and uses |
| 01/11/2007 | US20070009551 Aids ancestral viruses and vaccines |
| 01/11/2007 | US20070009550 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009544 Anti-allergic complex molecules |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/11/2007 | US20070009525 Human Endokine Alpha and Methods of Use |
| 01/11/2007 | US20070009524 Methods of treating inflammation associated with viral infection with anti-tnf antibodies |
| 01/11/2007 | US20070009521 Human tumor necrosis factor TR21 and methods based thereon |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009516 Immune response-associated proteins |
| 01/11/2007 | US20070009515 Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| 01/11/2007 | US20070009514 Prostaglandin receptor ep1 |
| 01/11/2007 | US20070009509 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor |
| 01/11/2007 | US20070009507 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/11/2007 | US20070009501 Squamous cell carcinoma antigens and use therefor |
| 01/11/2007 | US20070009498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 01/11/2007 | US20070009496 Method of growing myocardial cells |
| 01/11/2007 | US20070009489 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |
| 01/11/2007 | US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 01/11/2007 | US20070009486 Adenoviral vectors having a protein IX deletion |
| 01/11/2007 | US20070009481 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 01/11/2007 | US20070009479 Methods for treating dermatitis using mutant human IL-4 compositions |
| 01/11/2007 | US20070009478 Pegylated g-csf polypeptides and methods of producing same |
| 01/11/2007 | US20070009477 Methods for rational PEGylation of proteins |
| 01/11/2007 | US20070009442 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules |
| 01/11/2007 | DE60210297T2 Verwendung von langem pentraxin ptx3 für die behandlung von infertilität bei frauen Use of long pentraxin PTX3 for the treatment of infertility in women |
| 01/11/2007 | DE4342092B4 Langwirkende Injektionssuspension und Verfahren zur Herstellung Long-acting injection suspension and process for producing |
| 01/11/2007 | DE10306085B4 Neue Spleißvariante eines Proteinkinase A-Ankerproteins und Verwendung dieser New splice variant of a protein kinase A anchor protein and use of these |
| 01/11/2007 | DE102005037351B3 In vitro method for directed evolution of proteins, useful e.g. in pharmaceutical development, uses expression system for performing translation, transcription and reverse transcription |
| 01/11/2007 | DE102005031755A1 New peptides that bind to Salmonella, useful for immobilization, detection, concentration and labeling, optionally derivatized with a pharmaceutical |
| 01/11/2007 | DE102005029845A1 Verfahren zur Diagnose von rheumatischen Erkrankungen A method for the diagnosis of rheumatic diseases |
| 01/11/2007 | CA2656741A1 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites |
| 01/11/2007 | CA2650656A1 Cytokine receptor modulators and uses thereof |
| 01/11/2007 | CA2617859A1 Glp-1 pharmaceutical compositions |
| 01/11/2007 | CA2614066A1 Dehydrin genes and promoters from coffee |
| 01/11/2007 | CA2613867A1 Serum-free culture medium for the production of recombinant gonadotropins |
| 01/11/2007 | CA2613836A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 01/11/2007 | CA2613813A1 Protein preparation containing s1-5 |
| 01/11/2007 | CA2613320A1 Lefty, lefty derivatives and uses thereof |
| 01/11/2007 | CA2613057A1 Anti-malaria vaccine |
| 01/11/2007 | CA2613040A1 Method for preparing a covalently cross linked oligomer of amyloid beta peptides |
| 01/11/2007 | CA2612785A1 Polynucleotides and polypeptides of the il-12 family of cytokines |
| 01/11/2007 | CA2612241A1 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 01/11/2007 | CA2612239A1 Il-12/p40 binding proteins |
| 01/11/2007 | CA2611941A1 Composition and method for producing stable amyloid beta oligomers of high molecular weight |
| 01/10/2007 | EP1742062A2 Protein arrays for allelic variants and uses thereof |